HF pt 3 Flashcards

sowinski pg 67 - 105 (ACEi,ARBs, ARNIs)

1
Q

what drugs are approved to reduce mortality or mortality/hospitalization in chronic HFrEF?

A

metoprolol succinate, carvedilol, captopril, enalapril, rampiril, trandolapril, quinapril, fosinopril, lisinopril, candesartan, valsartan, entresto, spironolactone, eplerenone, isosorbide/hydralazine, bisoprolol (not US), farxiga, jardiance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what drugs are approved to reduce hospitalization only in chronic HFrEF?

A

digoxin
ivabradine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what drugs are approved to improve hemodynamic or physical function in chronic HFrEF?

A

digoxin
isosorbide/hydralazine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what drugs are used to improve hemodynamic or physical function in AHF?

A

inotropes
milrinone
sodium nitroprusside
nesiritide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what drugs are approved to improve QOL or symptoms in chronic HFrEF?

A

digoxin
diuretics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what drugs are approved to improve QOL or symptoms in AHF?

A

nesiritide
diuretics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what pt population would benefit from ACEi therapy?

A

benefit in all pts regardless of etiology or severity of disease, must be used in all without CI
additional benefits in IHD, CKD, post-MI, or DM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

when bradykinin is prevented from degraded by the use of ACEi, what happens?

A

increased NE, vasodilation, vessel permeability, and tPA/prostaglandin release

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

how does a cough develop with ACEi?

A

ACEi block the degradation of bradykinin which leads to the increase production of tPA/prostaglandin release which is what makes a cough occur

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what is the moa of ACEi?

A

inhibition of angiotensin I converting into angiotensin II

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what are the good effects of ACEi?

A

improved cardiac hemodynamics
reduced aldosterone
decreased endothelin-1
decreased arginine vasopressin
reduced vasoconstriction
reduce Na and water retention

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what is the dosing of enalapril (vasotec)?

A

initial: 2.5-5 mg BID
target: 10 mg BID

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what is the dosing of captopril?

A

initial: 6.25-12.5mg TID
target: 50mg TID

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what is the dosing of lisinopril (prinivil, zestril)?

A

initial: 2.5-5mg QD
target: 20mg QD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what is the dosing of quinapril (accupril)?

A

initial: 5-10mg BID
target: 20-40mg BID

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what is the dosing of ramipril (altace)?

A

initial: 1.25-2.5mg QD
target: 5mg BID or 10 mg QD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

what is the dosing of fosinopril (monopril)?

A

initial: 5-10 mgQD
target: 40 mg QD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

how should ACEi be dosed?

A

should be titrated to dose that shows reduction in mortality, not by symptoms or BP goal
start low and double dose every 1-4 weeks

19
Q

how should ACEi be dosed in CKD?

A

lower doses if CrCl is under 30 mL/min
1/2 of initial and 1/2 target mortality dose

20
Q

when should titrate of ACEi be cautioned?

A

if volume depleted and SBP under 80
if K over 5 and SeCr over 3

21
Q

what are absolute CI of ACEi?

A

pregnancy or intending to become pregnant
history of angioedema or hypersensitivity
bilateral renal artery stenosis
history of well-documented intolerance due to symptomatic hypotension, decline in renal function, hyperkalemia, or cough

22
Q

what should be monitored with ACEi/ARBs?

A

volume status (prior to initiation)
renal function and K
BP
other adverse effects

23
Q

when should renal function and K be monitored in ACEi/ARBs?

A

prior to therapy
1-2 weeks after each increase in dose
at 3-6 months intervals
when other treatments are added that may decrease renal function
in pts with hx of renal dysfunction

24
Q

what is an unacceptable increase in SeCr?

25
Q

what are AE of ACEi/ARBs?

A

hypotension
functional renal insufficiency
hyperkalemia
skin rash and dysgeusia
cough (ACEi only)
angioedema

26
Q

how do ARBs differ from ACEi?

A

no cough because it doesn’t block bradykinin degradation
blocks nonspecific chymas

27
Q

what is the dosing of losartan (cozaar)?

A

initial: 25-50mg daily
target: 150 mg daily

28
Q

what is the dosing valsartan (diovan)?

A

initial: 20-40 mg BID
target: 160 mg BID

29
Q

what is the dosing of candesartan (Atacand)?

A

initial: 4 mg daily
target: 32 mg daily

30
Q

when should an ARB be used?

A

unable to take ACEi due to cough
ACEi-induced angioedema

31
Q

if a pt has persistent Scr or K, does it make sense to switch from an ACEi to an ARB?

A

no
probably will see same effect

32
Q

what is moa of an ARNI?

A

part ARB so blocks the Angiotensin II from activating the AT1-receptor and inducing vasoconstriction
part Neprilysin inhibitor so stops Neprilysin from binding to BNP and blocking vasodilation

33
Q

what is the AE of ARNIs?

A

hypotension (more so than enalapril)
elevations in SeCr, SeK (less than enalapril)
angioedema rare
pregnancy

34
Q

how should entresto be dosed?

A

based on previous use of ACEi/ARB or other factors

35
Q

when should the initial dose of 49/51mg BID be used?

A

pt alr on high dose ACEi or high dose ARB

36
Q

when should initial dose of 24/26mg BID be used?

A

pt alr on medium to low dose ACEi/ARB
ACEi/ARB naive
eGFR under 30
moderate hepatic impairment
age over 75 years

37
Q

what is the equivalence of ACEi?

A

enalapril 20 = captopril 150 = lisinopril 20

38
Q

what are the CI of ARNI?

A

within 36 hours of ACEi use
angioedema with an ACEi or ARB previously
pregnancy
lactation
severe hepatic impairment
concomitant aliskiren use in pt with DM
known hypersensitivity

39
Q

what are the cautions of ARNI?

A

renal impairment
hepatic impairment
renal artery stenosis
hypotension
volume depletion
hyponatremia
post MI

40
Q

in what class is ACEi recommended?

A

Stage B
Stage C if ARNI use not feasible

41
Q

in what class is ARB use recommendeD?

A

Stage B if intolerant to ACEi
Stage C if intolerant to ACEi and ARNI not feasible
reasonable alternative in Stage C if taking an ARB for another indication

42
Q

in what stage is an ARNI recommended?

A

Stage C in all pts

43
Q

what is the monitoring of ARNIs?

A

BP
electrolytes
renal function
after initiation and during titration

44
Q

how should ARNIs be titrated?

A

after 2 weeks of usage, assess tolerability and titrate if possible dose stepwise to target dose of 97/103 mg BID